The angiogenic factors and their soluble receptors in sepsis: Friend, foe, or both?

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Zhang, Ru Yuan ^a   Liu, Yi Yun ^a   Qu, Hong Ping ^a   Tang, Yao Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; VASCULOTROPIN;

ANGIOGENESIS; CANCER THERAPY; CRITICALLY ILL PATIENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; LETTER; PRIORITY JOURNAL; SEPSIS;

EID: 84887539093     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/1364-8535-17-446     Document Type: Letter

References (5)

1. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, Simms BT, Mizgerd JP, Carmeliet P, Karumanchi SA, Aird WC. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006, 203:1447-1458. 10.1084/jem.20060375, 2118329, 16702604.
2. Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008, 12:R147. 10.1186/cc7130, 2646310, 19025590.
3. Kumpers P, van Meurs M, David S, Molema G, Bijzet J, Lukasz A, Biertz F, Haller H, Zijlstra JG. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care 2009, 13:R64. 10.1186/cc7866, 2717419, 19416526.
4. Jeong SJ, Han SH, Kim CO, Choi JY, Kim JM. Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis. Crit Care 2013, 17:R97. 10.1186/cc12742, 23710641.
5. Jesmin S, Zaedi S, Islam AM, Sultana SN, Iwashima Y, Wada T, Yamaguchi N, Hiroe M, Gando S. Time-dependent alterations of VEGF and its signaling molecules in acute lung injury in a rat model of sepsis. Inflammation 2012, 35:484-500. 10.1007/s10753-011-9337-1, 21528367.